Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization.

By S. Yusuf, S. Reddy, S. Ôunpuu, Sonia S Anand. Circulation, 2001

3,051 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Organizational Behavior and Human Resource Management

View Paper: https://www.semanticscholar.org/paper/468551b9f5df4172a954fcdcb1d3ff70f4bd940e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Julian F. Thayer
2. J. Brosschot
3. Sonia S Anand
4. T. Nakagawa
5. George Davey Smith
6. Richard J. Johnson
7. C. Bushnell
8. Y. Sautin

In Endocrinology, Diabetes and Metabolism

1. Julian F. Thayer
2. George Davey Smith
3. Richard J. Johnson
4. Barry M. Popkin
5. J. Brosschot
6. F. B. Hu

Citations in the corpus

• Epidemiology of coronary heart disease and acute coronary syndrome. (2016, background): “At the turn of the century, it was reported that CHD mortality was expected to increase approximately 29% in women and 48% in men in developed countries between 1990 and 2020; the corresponding estimated increases in developing countries were 120% in women and 137% in men (30).”
• The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors. (2010, background): “This is particularly true in developed countries [12,13].”
• Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. (2007, background): “As life expectancy continues to increase and economies become more industrialized, the burden of CVD on women and the global economy will continue to increase (5).”
• The double burden of communicable and non-communicable diseases in developing countries. (2006, background): “Nearly 80% of these deaths occur in low- and middle-income countries where the trend is increasing (Reddy and Yusuf, 1998; Yusuf et al., 2001 ), indicating that by the year 2010 CVD will be the leading cause of death, as a consequence of lifestyle changes brought about by industrialization and urba”
• International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. (2006, background): “and further accelerate the impact of atherothrombosis on morbidity and mortality.(22-24)”
• A life course approach to chronic disease epidemiology. (2005, background): “CHD remains a major cause of death in many industrialized countries and is rising alarmingly in developing countries (197, 198).”